Suchergebnisse
Suchergebnisse:
24. Apr. 2024 · McKinsey has faced repeated claims that its work for Purdue Pharma, the maker of OxyContin, and other drug manufacturers contributed to the US opioid crisis by advising the companies on how...
- Stefania Palma
24. Apr. 2024 · He led a criminal investigation into Purdue Pharma that resulted in the company’s guilty plea in 2007 to having misled regulators, doctors and patients about the dangers of OxyContin. “It is...
Vor 2 Tagen · WASHINGTON (AP) — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from...
Vor 2 Tagen · In August 2010, Purdue Pharma reformulated their long-acting oxycodone line, marketed as OxyContin, using a polymer, Intac, to make the pills more difficult to crush or dissolve in water to reduce non-medical use of OxyContin. The FDA approved relabeling the reformulated version as abuse-resistant in April 2013.
- By mouth: 60–87%
- AU: C
- C₁₈H₂₁NO₄
- OxyContin, Endone, others
Vor 6 Tagen · In 2019, Purdue Pharma, the maker of opioid painkiller OxyContin, faced extensive litigation for its role in the opioid epidemic and filed for bankruptcy.It was one of several landmark legal actions that opened the door to industry accountability, addressing the role of big pharma in fuelling the opioid crisis.
25. Apr. 2024 · Reuters. Wed 24 Apr 2024 20.15 EDT. McKinsey is under criminal investigation in the United States over allegations that the consulting firm played a key role in fueling the opioid epidemic, with...
28. Apr. 2024 · 1. First Bottle. Richard Sackler launches a powerful new painkiller. But is the drug safe to be released? 59 mins. 2. Breakthrough Pain. OxyContin hits the market as Purdue Pharma's vast...
